Kevin Koch

Chief Executive Officer at EDGEWISE THERAPEUTICS, INC.

Net worth: 16 M $ as of 30/08/2026

65 year

76 connections

Health Technology

Consumer Services

Finance

Profile

Dr. Kevin Koch is a President, Chief Executive Officer & Director at Edgewise Therapeutics, Inc. and a Venture Partner at OrbiMed Advisors Private Equity.
He is on the Board of Directors at Edgewise Therapeutics, Inc., Encycle Therapeutics, Inc., Neurogastrx, Inc. and Skyhawk Therapeutics, Inc. Dr. Koch was previously employed as an Independent Director by Miragen Therapeutics, Inc., a Senior Vice President by Biogen, Inc., a President & Chief Scientific Officer by Array BioPharma, Inc., an Associate Director-Medicinal Chemistry by Amgen, Inc., and a Senior Research Investigator by Pfizer Inc. He also served on the board at Terremoto Biosciences, Inc., Inflammation Research Association, Inc. and Ataxion, Inc. He received his undergraduate degree from Stony Brook University, a graduate degree from the University of Rochester and a doctorate degree from the University of Rochester.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
EDGEWISE THERAPEUTICS, INC. 0.36%	11/08/2026	391,272 ( 0.36% )	16 M $	30/08/2026

Kevin Koch active positions

Companies	Position	Start
EDGEWISE THERAPEUTICS, INC.	Chief Executive Officer	31/07/2017
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Private Equity Investor	30/04/2016
Encycle Therapeutics, Inc. Encycle Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services	Director/Board Member	-
Neurogastrx, Inc. Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders	Director/Board Member	03/01/2018
Skyhawk Therapeutics, Inc. Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases	Director/Board Member	-

All active positions of Kevin Koch

Former positions of Kevin Koch

Companies	Position	End
Terremoto Biosciences, Inc. Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases	Director/Board Member	30/11/2023
VIRIDIAN THERAPEUTICS, INC.	Director/Board Member	27/10/2020
BIOGEN INC.	Corporate Officer/Principal	31/08/2015
ARRAY TECHNOLOGIES, INC.	Founder	28/11/2013
░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Kevin Koch's experience

Training of Kevin Koch

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Koch's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Array BioPharma, Inc. Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs	Health Technology
Stony Brook University Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Finance
Inflammation Research Association, Inc. Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology	Commercial Services
Ataxion, Inc. Ataxion, Inc. BiotechnologyHealth Technology Develops novel therapies for rare, debilitating, and underserved neurologic diseases	Health Technology
Encycle Therapeutics, Inc. Encycle Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services	Health Technology
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products	Health Technology
Neurogastrx, Inc. Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders	Health Technology
Skyhawk Therapeutics, Inc. Skyhawk Therapeutics, Inc. BiotechnologyHealth Technology Develops novel RNA-targeting small molecule for neurology, oncology and fibrotic diseases	Health Technology
Edgewise Therapeutics, Inc. Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases	Health Technology
Terremoto Biosciences, Inc. Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases	Health Technology